Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 9, 2009, Pages 1400-1408

  Verder, Henrik ^a   Bohlin, Kajsa ^b   Kamper, Jens ^c   Lindwall, Robert ^d   Jonsson, Baldvin ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d DANDERYD HOSPITAL   (Sweden)

Author keywords

Bronchopulmonary dysplasia; Continuous positive airway pressure; Non invasive positive pressure ventilation; Respiratory distress syndrome; Surfactant

Indexed keywords

CAFFEINE CITRATE; NITRIC OXIDE; SURFACTANT;

APNEA; ARTIFICIAL VENTILATION; HUMAN; LUNG DYSPLASIA; NON INVASIVE PROCEDURE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT INTUBATION; RETROLENTAL FIBROPLASIA; REVIEW; SCANDINAVIA; VERY LOW BIRTH WEIGHT;

APNEA; BRONCHOPULMONARY DYSPLASIA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRATES; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 68549120977     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01413.x     Document Type: Review

References (92)

1. Saugstad O. Chronic lung disease: oxygen dogma revisited. Acta Paediatr 2001 90 : 113 5.
2. Askie LM, Henderson-Smart DJ, Irwing L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003 349 : 959 67.
3. Rhodes PG, Hall RT. Continuous positive airway pressure delivered by face mask in infants with idiopathic respiratory distress syndrome: a controlled study. Pediatrics 1973 52 : 17 21.
4. Dunn PM. Respiratory distress syndrome. Continuous positive airway pressure (CPAP) using the Gregory box. Proc R Soc Med 1984 67 : 245 7.
5. Bancalari E, Sinclair JC Mechanical ventilation. In : Sinclair JC, Bracken MB, editors. Effective care of the newborn infant. Oxford : Oxford University Press, 1992.
6. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972 50 : 515 25.
7. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980 I : 55 9.
8. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994 331 : 1051 5.
9. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns less than 30 weeks's gestation. Pediatrics 1999 103 : e24.
10. Kroner J, Hjelt K, Nielsen JE, Kardorf UB, Verder H. Den neonatale mortalitet, morbiditet og senfølger hos børn med fødselsvægt mindre end 1501 g. eller svangerskabslængde mindre end fulde 31 uger, primært indlagt på et centralsygehus. Ugeskr Laeger 1995 157 : 5707 11.
11. Lagercrantz H. Editorial. Does CPAP work when it really matters? Acta Paediatr 2007 96 : 481.
12. Kamper J, Wulff K, Larsen C, Lindequist S. Early treatment of airway pressure in very low-birth-weight infants. Acta Paediatr 1993 82 : 193 7.
13. Roberton NRC. Does CPAP work when it really matters? Acta Paediatr 1993 82 : 206 7.
14. Verder H. Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatr 2007 96 : 482 4.
15. Bohlin K, Bohaufs RK, Jarstrand C, Curstedt T, Blennow M, Robertson B. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits. Pediatr Res 2005 57 : 624 30.
16. van Marter LJ, Dammann O, Alred EN, Leviton A, Pagano M, Moore M, et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002 140 : 171 6.
17. Jobe AH, Hillman N, Polglase G, Kramer BW, Kallapur S, Pillow J. Injury and inflammation from resuscitation of the preterm infant. Neonatology 2008 94 : 190 6.
18. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997 42 : 348 55.
19. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory distress syndrome with continuous positive airway pressure. N Engl J Med 1971 284 : 1333 40.
20. Svenningsen NW, Jonson B, Lindroth M, Ahlström H. Consecutive study of early CPAP - application in hyaline membrane disease. Eur J Pediatr 1979 131 : 9 19.
21. 2 monitoring during treatment with continuous positive airway pressure in infants with idiopathic respiratory distress syndrome. Acta Anaesth Scand 1983 27 : 1 4.
22. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in very-low birth-weight infants preventable? A survey of eight centers. Pediatrics 1987 79 : 26 30.
23. Polin RA, Sahni R. Newer experience with CPAP. Semin Neonatol 2002 7 : 379 89.
24. Morley CJ, Davis PG, Doyle LW, Brion NP, Hascoet JM, Carlin JB, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008 358 : 700 8.
25. Saunders RA, Milner AD, Hopkin IE. The effects of continuous positive airway pressure on lung mechanics lung volumes in the neonate. Biol Neonate 1976 29 : 178 86.
26. Putman E, van Golde LM, Haagsman HP. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 1993 175 : 75 103.
27. Teusch H, Wyszogrodski I, Wang N. Pulmonary pressure-volume relationships in premature fetal and newborn rabbits. J Appl Physiol 1974 37 : 809 13.
28. Goodwin S, Graves S, Haberkern C. Aspiration in intubated premature infants. Pediatrics 1985 61 : 85 8.
29. Javorka K, Tomori Z, Zavarska E. Effect of lung inflation on the respiratory frequency and heart rate of premature neonates. Physiol Bohemoslov 1982 31 : 129 35.
30. Greenough A. Lung reflexes. Acta Paediatr 1993 389 : 50 2.
31. Thomson MA, Yoder BA, Winte VT, Martin H, Catland D, Siler-Kohdr TM, et al. Treatment of immature baboons for 28 days with early nasal continuous positive nasal pressure. Am J Respir Crit Care Med 2004 169 : 1054 62.
32. Loeliger M, Inder T, Cain S, Ramesh RC, Camm E, Thomson MA, et al. Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics 2006 118 : 1640 53.
33. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M. Decreased indicators of lung injury with continuous positive airway pressure in preterm lambs. Pediatr Res 2002 52 : 387 92.
34. Caliumi-Pellegrini G, Agostino R, Orzalesi M, Nodari S, Marzetti G, Savignoni PG, et al. Twin nasal cannula for administration of continuous positive airway pressure to newborn infants. Arch Dis Child 1974 49 : 228 30.
35. Gherini S, Peters R, Virgilio R. Mechanical work of the lungs and the work of breathing with positive end expiratory pressure and continuous positive airway pressure. Chest 1979 76 : 251 4.
36. De Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev 2008 1 : CD002977.
37. Jonson B, Ahlström H, Lindroth M, Swenningsen NW. Continuous positive airway pressure: modes of action in relation to clinical applications. Ped Clin North Am 1980 27 : 687 96.
38. Jonsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H. Neonatal care of very-low-birthweight infants in special-care units and neonatal intensive-care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses. Acta Paediatr 1997 419 (Suppl. 4 10.
39. Kamper J, Feilberg Jørgensen N, Jonsbo F, Pedersen-Bjerregaard L, Pryds O. The Danish national study in infants with extremely low gestational age and birth weight (the ETFOL study): respiratory morbidity and outcome. Acta Paediatr 2004 93 : 225 32.
40. Benveniste D, Berg O, Pedersen JE. A new technique for delivery of continuous positive airway pressure to the neonate. J Pediatr 1976 88 : 1015 9.
41. Moa G, Nilsson K, Zetterström H, Jonsson LO. A new device for administration of nasal continuous positive airway pressure in the newborn: an experimental study. Critic Care Med 1988 16 : 1238 42.
42. Lee KS, Dunn MS, Fenwick M, Shennan AT. A comparison of underwater bubble continuous positive airway pressure with ventilatior-derived continuous positive airway pressure in premature neonates ready for extubation. Biol Neonate 1998 73 : 69 75.
43. Morley CJ, Lau R, De Paoli A, Davis PG. Nasal continuous positive airway pressure: does bubbling improve gas exchange? Arch Dis Child Fetal Neonatal Ed 2005 90 : 343 4.
44. Kahn DJ, Courtney SE, Steele AM, Habib RH. Unpredictability of delivered bubble nasal continuous positive airway pressure: role of bias flow magnitude and prong-nares air leaks. Pediatr Res 2007 62 : 343 7.
45. Pillow JJ, Hillman N, Moss TJ, Polgase G, Bold G, Beaumont C, et al. Bubble continuous positive airway pressure enhances lung volume and gas exchange in preterm lambs. Am J Respir Crit Care Med 2007 176 : 63 9.
46. Gupca S, Sinha SK, Tin W, Donn SM. A randomized controlled trial of post-extubation bubble continuous positive airway pressure versus infant flow driver continuous positive airway pressure in preterm infants with respiratory distress syndrome. J Pediatr 2009 154 : 645 50.
47. Courtney SE, Pyon KH, Saslow JG, Arnold GK, Pandit PB, Habib RH. Lung recruitment and breathing pattern during variable versus continuous positive airway pressure in premature infants: an evaluation of these devices. Pediatrics 2001 107 : 304 8.
48. Pantalitschka T, Sievers J, Urschitz MS, Herberts T, Reher C, Poets CF. Randomized crossover trial of four nasal respiratory support systems on apnoea of prematurity in very low birth weight infants. Arc Dis Child Fetal Neonatal Ed 2009 doi :.
49. Keenan SP, Kernerman PD, Cook DJ, Martin CM, McCormack D, Sibbald WJ. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med 1997 25 : 1685 92.
50. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000 105 : 1194 201.
51. Ali N, Clure N, Alegria X, D'Ugard C, Organero R, Bancalari E. Effects of noninvasive pressure support ventilation (NI-PSV) on ventilation and respiratory effort in very low birth weight infants. Pediatr Pulmonol 2007 42 : 704 10.
52. Aghai ZH, Shaslow JG, Nalhla T, Milcarec B, Hart J, Lawrysh-Plunkett R, et al. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to continuous positive airway pressure (NCPAP). Pediatr Pulmonol 2006 41 : 875 81.
53. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003 2 : CD000143.
54. Lemyre B, Davis PG, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database Syst Rev 2002 1 : CD002272.
55. Davis PG, Lemyre B, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev 2001 3 : CD003212.
56. Santin R, Brodsky N, Bhandari V. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (sNIPPV) as a primary mode of ventilation in infant > or =28 weeks with respiratory distress. J Perinatol 2004 24 : 487 93.
57. Manzar S, Nair AK, Pai M, Paul J, Manikoth P, Georage M, et al. Use of nasal intermittent positive pressure ventilation to avoid intubation in neonates. Saudi Med J 2004 25 : 1464 7.
58. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr 2007 150 : 521 6.
59. Te Pas AB, Spaans VM, Rijken M, Morley CJ, Walther FJ. Early nasal continuous positive airway pressure and low threshold for intubation in very preterm infants. Acta Paediatr 2008 97 : 1049 54.
60. Victorin LH, Deverajan LV, Curstedt T, Robertson B. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease - a pilot study. Biol Neonate 1990 58 : 121 6.
61. Verder H, Agertoft L, Albertsen P, Christensen NC, Curstedt T, Ebbesen F, et al. Surfaktant behandling af nyfødte med respiratorisk distress-syndrom primært behandlet med nasalt kontinuerligt positivt luftvejstryk. Ugeskr Laeger 1992 154 : 2136 9.
62. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment duringcontinuous positive airway pressure. J Perinatol 2007 27 : 422 7.
63. Stevens TP, Blennow M, Meyers EH, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007 4 : CD003063.
64. Jobe A. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 2003 8 : 9 17.
65. Groneck P, Schmale J, Soditt V, Stützer B, Goetze-Speer B, Speer CP. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 2001 31 : 331 8.
66. Torday JS, Rehan VK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res 2007 62 : 2 7.
67. Kirschner L, Weninger M, Unterasinger L, Birnbacher R, Hayde M, Krepler R, et al. Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the Vermont Oxford Neonatal Network. J Perinat Med 2005 33 : 60 6.
68. Engle WA. Surfactant-replacement therapy for respiratory distress in preterm and term neonates. Pediatrics 2008 121 : 419 32.
69. Chong E, Greenspan J, Kirkby S, Culhane J, Dysart K. Changing use of surfactant over 6 years and its relationship to chronic lung disease. Pediatrics 2008 122 : e917 21.
70. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001 2 : CD000510.
71. Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 1999 4 : CD001456.
72. The Osiris Collaborative Group. Early versus delayed administration of a synthetic surfactant - the judgment of Osiris. Lancet 1992 340 : 1363 9.
73. Halliday HL, Tarnow-Mordi WO, Cocoran JD, Patterson CC. Multicentre randomised trial comparing high and low dosis surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 1993 69 : 276 80.
74. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure - a randomized controlled trial. Pediatrics 2009 123 : 137 42.
75. Birenbaum HJ, Dentry A, Cirelli J, Helou S, Pane MA, Starr K, et al. Reduction in the incidence of chronic lung disease in very low birth weight infants: Results of a quality improvement process in a tertiary level neonatal intensive care unit. Pediatrics 2009 123 : 44 50.
76. Sandri F, Simeoni U, Plavka R on behalf of the CURPAP study group. CURPAP study - an international randomised controlled trial to evaluate the efficacy of combining prophylactic surfactant and early nasal CPAP in very preterm infants. Baltimore, MD : The PAS Meeting, 2009. Abstract 4110.
77. Ramanathan R. Optimal ventilatory strategies and surfactant to protect the preterm lungs. Neonatalogy 2008 93 : 302 8.
78. Robertson B, Halliday HL. Principles of surfactant replacement. Biochim Biophys Acta 1998 1408 : 346 61.
79. Pereira eSilva Y, Gomes RS, Marcatto JO, Maximo TA, Barbosa RF, Simões eSilva AC. Morphine versus remifentanil for intubating preterm infants. Arch Dis Child Fetal Neonatal Ed 2007 92 : 293 4.
80. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology 2008 93 : 284 7.
81. Barbé F, Hansen C, Badonnel Y, Legagneur H, Vert P, Boutroy MJ, et al. Severe side effects and drug plasma concentrations in preterm infants with Doxapram. Ther Drug Monit 1999 21 : 547 52.
82. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 2005 115 : 655 61.
83. Wilson-Costello MD, Walsh MC, Langer JC, Guillet R, Laptook MD, Stoll BJ, et al. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months′ adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics 2009 123 : e430 7.
84. Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, et al. European consensus guidelines on management of neonatal respiratory distress syndrome. J Perinat Med 2007 35 : 175 86.
85. Kribs A, Vierzig A, Hünsler C, Eifinger F, Stützer H, Roth B. Early surfactant in spontaneously breathing with nCPAP in ELBW infants - a single centre four years experience. Acta Paediatr 2008 97 : 293 8.
86. Castillo A, Sola A, Baquero H, Neira F, Alvis R, Deulofeut R, et al. Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range? Pediatrics 2008 121 : 882 9.
87. Walford G, Loscalzo J. Nitric oxide in vascular biology. J Thromb Haemost 2003 1 : 2112 8.
88. Schedin U, Norman M., Gustafsson LE, Jonsson B, Frostell C. Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr 1997 86 : 1229 35.
89. Schreiber MD, Gin-Mestan K, Marks JD, Hou D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with respiratory distress syndrome. N Engl J Med 2003 349 : 2099 107.
90. Lindwall R, Blennow M, Svensson M, Jonsson B, Berggren-Boström E, Flanby M, et al. A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome. Intensive Care Med 2005 23 : 773 9.
91. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 2004 287 : L344 51.
92. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2005 288 : L450 9.